Ocular Therapeutix, Inc. (OCUL) earnings
OCUL earnings moved a median of -0.08% by the close. Quarterly and annual OCUL reports and results, each read against the price at its own news timestamp. Back to the OCUL overview →
29 measured OCUL earnings events.
Where these OCUL earnings landedvs 28 measured OCUL earnings reactions
| Middle 50% of OCUL earnings reactions | -3.38% to +4.11% |
|---|---|
| Median reaction (to close) | -0.08% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 OCUL earnings events with a measured close landed between -3.38% and +4.11%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q OCULAR THERAPEUTIX, INC For: Jun 30 | SEC filing · Form 10-Q | -0.60% | +0.60% | |
| Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights | Press release | -0.60% | +0.60% | |
| Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026 | Press release | -3.59% | +4.90% | |
| Form 10-Q OCULAR THERAPEUTIX, INC For: Mar 31 | SEC filing · Form 10-Q | +5.25% | +3.96% | |
| Ocular Therapeutix™ Reports First Quarter 2026 Financial Results and Business Highlights | Press release | +5.25% | +3.96% | |
| Ocular Therapeutix™ to Report First Quarter 2026 Financial Results on May 5, 2026 | Press release | +1.36% | -2.81% | |
| Form 10-K OCULAR THERAPEUTIX, INC For: Dec 31 | SEC filing · Form 10-K | +6.09% | +0.68% | |
| Form 10-Q OCULAR THERAPEUTIX, INC For: Sep 30 | SEC filing · Form 10-Q | -5.09% | -2.68% | |
| Ocular Therapeutix™ Reports Third Quarter 2025 Financial Results and Business Highlights | Press release | -5.09% | -2.68% | |
| Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025 | Press release | +0.09% | +0.09% | |
| Form 10-Q OCULAR THERAPEUTIX, INC For: Jun 30 | SEC filing · Form 10-Q | -4.48% | +7.05% | |
| Ocular Therapeutix™ Reports Second Quarter 2025 Financial Results and Business Highlights | Press release | -4.48% | +7.05% | |
| Ocular Therapeutix™ to Report Second Quarter 2025 Financial Results on August 5, 2025 | Press release | -0.57% | — | |
| Form 10-Q OCULAR THERAPEUTIX, INC For: Mar 31 | SEC filing · Form 10-Q | +3.99% | -3.38% | |
| Ocular Therapeutix™ Reports First Quarter 2025 Results and Business Highlights | Press release | +3.99% | -3.38% | |
| Ocular Therapeutix™ to Report First Quarter 2025 Financial Results on May 5, 2025 | Press release | +0.77% | +4.77% | |
| Form 10-K OCULAR THERAPEUTIX, INC For: Dec 31 | SEC filing · Form 10-K | +1.87% | -14.63% | |
| Form 10-Q OCULAR THERAPEUTIX, INC For: Sep 30 | SEC filing · Form 10-Q | -3.03% | -6.06% | |
| Ocular Therapeutix™ Reports Third Quarter 2024 Results and Business Highlights | Press release | -3.03% | -6.06% | |
| Ocular Therapeutix™ to Report Third Quarter 2024 Results on November 14, 2024 | Press release | -0.86% | -0.36% | |
| Form 10-Q OCULAR THERAPEUTIX, INC For: Jun 30 | SEC filing · Form 10-Q | -3.69% | -0.24% | |
| Ocular Therapeutix™ Reports Second Quarter 2024 Results | Press release | -3.69% | -0.24% | |
| Ocular Therapeutix™ to Report Second Quarter 2024 Financial Results on August 7, 2024 | Press release | +0.12% | +0.95% | |
| Form 10-Q OCULAR THERAPEUTIX, INC For: Mar 31 | SEC filing · Form 10-Q | +0.70% | +4.54% | |
| Ocular Therapeutix™ Reports First Quarter 2024 Results | Press release | +0.70% | +4.54% | |
| Form 10-K OCULAR THERAPEUTIX, INC For: Dec 31 | SEC filing · Form 10-K | +3.63% | -5.11% | |
| Form 10-Q OCULAR THERAPEUTIX, INC For: Sep 30 | SEC filing · Form 10-Q | -2.95% | -9.04% | |
| Ocular Therapeutix™ Provides Third Quarter 2023 Financial Results and Corporate Update | Press release | -2.95% | -9.04% | |
| Ocular Therapeutix™ To Report Third Quarter 2023 Financial Results | Press release | +0.00% | +4.70% |
Keep exploring
More OCUL: analyst actions → · SEC filings → · OCUL overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AMPLIPHI BIOSCIENCES CORP (APHB) | 422 | -0.98% | 32% |
| Henry Schein, Inc. (HSIC) | 422 | -0.08% | 44% |
| ASTERIAS BIOTHERAPEUTICS INC (AST) | 416 | -0.53% | 34% |
| BIOPHARMX CORP (BPMX) | 416 | -1.58% | 28% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.